Avient
AVNT
41.00
-0.49
-1.18%
Avient
US · AVNT
#2315 by market cap
Listed 1970
41.00
-0.49
-1.18%
Live - 5344 symbols - heartbeat 220s ago
· 2026-10-08 08:28
Pre-market
40.90
-0.24%
After-hours
41.00
0.00%
Overnight
40.99
-0.02%
- Market cap
- 3.76B
- P/E (TTM)i
- 22.16
- P/Bi
- 1.54
- EPSi
- 0.89
- Div yieldi
- 2.67%
- 52W posi
- 73%
Reader sentiment
Are you bullish or bearish on AVNT?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Fair
- Altman Z-Score is 1.82, in the 1.8-3.0 "grey zone".
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +0.61% YoY
Margins
- Gross margin
- 31.15%
- Operating margin
- 6.24%
- Net margin
- 2.51%
Key ratios & quality
- Enterprise valuei
- 5.19B
- Altman Z-Scorei
- 1.82
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 2.88B | 2.86B | 3.24B | 3.32B | 3.40B | 3.14B | 3.24B | 3.26B |
| Gross profit | 624.80M | 657.20M | 784.30M | 943.80M | 882.70M | 892.50M | 1.06B | 1.02B |
| Selling & admin expenses | 446.20M | 500.40M | 595.00M | 664.10M | 639.40M | 695.70M | 727.40M | 812.10M |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | 178.60M | 156.80M | 189.30M | 279.70M | 243.30M | 196.80M | 329.30M | 203.50M |
| Pretax profit | 101.80M | 109.40M | 139.00M | 203.50M | 63.80M | 87.30M | 224.80M | 111.70M |
| Tax | 14.40M | 33.70M | 5.20M | 51.90M | -19.30M | 11.00M | 54.10M | 28.10M |
| Net profit | 159.50M | 588.80M | 133.40M | 230.60M | 703.40M | 76.20M | 170.70M | 83.60M |
| Basic EPS | 2 | 8 | 1 | 3 | 8 | 1 | 2 | 1 |
| Diluted EPS | 1.99 | 7.58 | 1.45 | 2.51 | 7.63 | 0.83 | 1.84 | 0.89 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 826.60M | 866.50M | 806.50M | 760.60M | 847.40M | 917.00M |
| Gross profit | 263.20M | 277.90M | 244.90M | 229.60M | 272.60M | 307.60M |
| Selling & admin expenses | 262.50M | 181.80M | 177.80M | 190.00M | 176.80M | 195.20M |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 700.00K | 96.10M | 67.10M | 39.60M | 95.80M | 112.40M |
| Pretax profit | -26.60M | 70.90M | 42.90M | 24.50M | 72.30M | 89.10M |
| Tax | -6.70M | 17.40M | 10.10M | 7.30M | 16.50M | 23.40M |
| Net profit | -19.90M | 53.50M | 32.80M | 17.20M | 55.80M | 65.70M |
| Basic EPS | 0 | 1 | 0 | 0 | 1 | 1 |
| Diluted EPS | -0.22 | 0.57 | 0.36 | 0.18 | 0.61 | 0.70 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 998.80M | 1.51B | 1.60B | 1.83B | 1.57B | 1.41B | 1.42B | 1.40B |
| Cash & ST investments | 170.90M | 864.70M | 649.50M | 601.20M | 641.10M | 545.80M | 544.50M | 510.50M |
| Inventory | 284.60M | 260.90M | 327.50M | 305.80M | 372.70M | 347.00M | 346.80M | 367.20M |
| Total assets | 2.72B | 3.27B | 4.87B | 5.00B | 6.09B | 5.97B | 5.81B | 6.03B |
| Total current liabilities | 557.60M | 702.50M | 801.00M | 940.60M | 869.40M | 773.60M | 756.10M | 846.30M |
| Short-term debt | 19.40M | 39.40M | 43.70M | 29.70M | 19.20M | 26.10M | 25.90M | 18.90M |
| Long-term debt | 1.34B | 1.21B | 1.85B | 1.85B | 2.18B | 2.07B | 2.06B | 1.92B |
| Total liabilities | 2,182,700,000.00 | 2,220,600,000.00 | 3,158,800,000.00 | 3,206,700,000.00 | 3,732,200,000.00 | 3,630,500,000.00 | 3,481,500,000.00 | 3,639,300,000.00 |
| Total equity | 540.60M | 1.05B | 1.71B | 1.79B | 2.35B | 2.34B | 2.33B | 2.39B |
| Retained earnings | 472.90M | 1.00B | 1.06B | 1.21B | 1.82B | 1.81B | 1.88B | 1.87B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 1.43B | 1.49B | 1.42B | 1.40B | 1.42B | 1.53B |
| Cash & ST investments | 456.00M | 474.50M | 445.60M | 510.50M | 427.60M | 425.60M |
| Inventory | 372.80M | 387.50M | 392.10M | 367.20M | 386.40M | 443.00M |
| Total assets | 5.81B | 6.13B | 6.06B | 6.03B | 5.94B | 6.00B |
| Total current liabilities | 698.20M | 737.30M | 701.60M | 846.30M | 803.10M | 806.90M |
| Short-term debt | 7.80M | 500.00K | 500.00K | 18.90M | 500.00K | 500.00K |
| Long-term debt | 2.06B | 2.02B | 1.97B | 1.92B | 1.92B | 1.88B |
| Total liabilities | 3,496,800,000.00 | 3,759,300,000.00 | 3,667,400,000.00 | 3,639,300,000.00 | 3,526,800,000.00 | 3,554,800,000.00 |
| Total equity | 2.31B | 2.37B | 2.39B | 2.39B | 2.42B | 2.45B |
| Retained earnings | 1.84B | 1.87B | 1.87B | 1.87B | 1.90B | 1.94B |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 253.70M | 300.80M | 221.60M | 233.80M | 398.40M | 201.60M | 256.80M | 301.60M |
| Depreciation & amortization | 91.50M | 87.50M | 115.00M | 145.90M | 163.10M | 188.80M | 179.70M | 185.90M |
| Free cash flow | 177.70M | 219.10M | 157.90M | 133.20M | 292.90M | 82.20M | 134.90M | 195.00M |
| Dividends paid | -56.10M | -60.30M | -71.30M | -77.70M | -86.80M | -90.20M | -94.00M | -98.80M |
| Stock buybacks / issuance | -123.00M | -26.90M | 473.70M | -4.20M | -36.40M | -- | -- | -- |
| Ending cash balance | 170.90M | 864.70M | 649.50M | 601.20M | 641.10M | 545.80M | 544.50M | 510.50M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | -51.10M | 112.80M | 72.10M | 167.80M | -34.50M | 93.80M |
| Depreciation & amortization | 45.30M | 46.60M | 46.90M | 47.10M | 47.90M | 48.80M |
| Free cash flow | -63.60M | 85.80M | 47.40M | 125.40M | -53.50M | 71.50M |
| Dividends paid | -24.70M | -24.70M | -24.70M | -24.70M | -25.20M | -25.20M |
| Stock buybacks / issuance | -- | -- | -- | -- | -- | -- |
| Ending cash balance | 456.00M | 474.50M | 445.60M | 510.50M | 427.60M | 425.60M |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 28.07 | 73.95 | 9.57 | 13.30 | 34.22 | 3.25 | 7.32 | 3.49 |
| ROA %i | 5.89 | 19.63 | 3.23 | 4.68 | 12.69 | 1.26 | 2.88 | 1.38 |
| ROIC %i | 11.10 | 29.70 | 6.79 | 7.82 | 19.27 | 3.91 | 5.60 | 3.52 |
| 5-year avg ROE %i | 14.21 | 27.19 | 25.20 | 23.23 | 31.82 | 26.86 | 13.53 | 12.32 |
| EBIT margin %i | 7.36 | 5.90 | 6.59 | 7.88 | 5.40 | 6.45 | 10.20 | 6.45 |
| FCF / sales %i | 5.03 | 7.65 | 4.87 | 2.76 | 8.62 | 2.62 | 4.16 | 5.98 |
| Current ratioi | 1.79 | 2.15 | 2.00 | 1.94 | 1.81 | 1.82 | 1.88 | 1.66 |
| Quick ratioi | 0.93 | 1.70 | 1.46 | 1.11 | 1.24 | 1.22 | 1.25 | 1.12 |
| Debt / assetsi | 49.78 | 39.50 | 40.11 | 38.37 | 36.76 | 35.85 | 36.98 | 33.20 |
| LT debt / equityi | 247.44 | 119.18 | 112.54 | 106.36 | 94.99 | 91.14 | 91.75 | 83.46 |
| Interest coveragei | 4.14 | 2.84 | 2.86 | 5.05 | 1.53 | 1.76 | 3.13 | 2.13 |
| Revenue CAGR (3Y) %i | -0.55 | -0.87 | 7.77 | 4.79 | 5.87 | -1.03 | -0.76 | -1.36 |
| Net income CAGR (3Y) %i | 3.39 | 52.73 | -- | 13.04 | 6.10 | -16.83 | -9.78 | -51.16 |
| FCF CAGR (3Y) %i | 6.02 | 15.18 | 8.74 | -9.16 | 10.16 | -19.56 | 0.42 | -12.68 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 4.33 | 5.09 | 4.79 | 3.49 | 6.71 | 7.09 |
| ROA %i | 1.71 | 1.97 | 1.87 | 1.38 | 2.68 | 2.80 |
| ROIC %i | 4.13 | 4.53 | 4.35 | 3.52 | 5.26 | 5.49 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 7.34 | 8.04 | 7.76 | 6.45 | 9.27 | 9.61 |
| FCF / sales %i | 4.28 | 4.60 | 4.65 | 5.98 | 6.25 | 5.73 |
| Current ratioi | 2.05 | 2.03 | 2.03 | 1.66 | 1.77 | 1.90 |
| Quick ratioi | 1.35 | 1.35 | 1.33 | 1.12 | 1.17 | 1.21 |
| Debt / assetsi | 35.61 | 32.94 | 32.56 | 33.20 | 32.37 | 31.24 |
| LT debt / equityi | 89.69 | 85.65 | 83.09 | 83.46 | 79.97 | 76.95 |
| Interest coveragei | 2.24 | 2.52 | 2.49 | 2.13 | 3.25 | 3.51 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Lead segment, long tail
- Color, Additives and Inks is the largest reported line at 62.62% of revenue, across 3 reported segments.
- Specialty Engineered Materials follows at 37.50%, so the top line still matters most but isn’t the whole story.
Revenue breakdown most recent period
Business
Color, Additives and Inks62.62%
Specialty Engineered Materials37.50%
Quote time 2026-10-08 08:28:52 · For reference only, not investment advice and not tailored to your situation.